4.8 Editorial Material

It's in the Milk: Feeding the Microbiome to Promote Infant Growth

期刊

CELL METABOLISM
卷 23, 期 3, 页码 393-394

出版社

CELL PRESS
DOI: 10.1016/j.cmet.2016.02.015

关键词

-

向作者/读者索取更多资源

Malnutrition is a global health burden affecting the development of millions of children worldwide, but the effects of current treatment strategies are modest. Charbonneau et al. (2016) identify sialylated oligosaccharides in breast milk as microbiota-dependent growth-promoting metabolites, paving the way for a new rational treatment of severe infant stunting.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Immunology

Phages and their potential to modulate the microbiome and immunity

Sara Federici, Samuel P. Nobs, Eran Elinav

Summary: Bacteriophages, as potential treatments against antibiotic-resistant bacterial infections, have gained renewed interest in utilizing them as therapeutic vectors and modulators of the human microbiome, with advancements in understanding their mechanisms through next-generation sequencing. The narrow host range, antibacterial repertoire, and ease of manipulation of phages offer promising possibilities for targeted modulation of pathogenic, commensal, and pathobiont microbiome members for impacting mammalian physiology and immunity.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Review Immunology

The NLRP6 inflammasome

Danping Zheng, Lara Kern, Eran Elinav

Summary: NLRP6, a member of the NOD-like receptor family, acts as a cytosolic innate immune sensor recognizing microbial patterns. It can form an inflammasome to mediate the maturation and secretion of pro-inflammatory cytokines, but also exerts functions independently of the inflammasome, playing a critical role in maintaining tissue homeostasis.

IMMUNOLOGY (2021)

Article Microbiology

Utilization of Host and Microbiome Features in Determination of Biological Aging

Karina Ratiner, Suhaib K. Abdeen, Kim Goldenberg, Eran Elinav

Summary: The term 'old age' generally refers to a period characterized by profound changes in human physiological functions and susceptibility to disease. Quantifying aging based on life years does not necessarily reflect how the human body ages, while characterizing biological aging based on functional parameters may better reflect a person's physiological status and disease susceptibility. The gut microbiome changes along with physiological aging and may play a pivotal role in age-related diseases, and integration of gut microbiome data and host parameters using artificial intelligence and machine learning may enable more accurate definition of aging clocks.

MICROORGANISMS (2022)

Review Endocrinology & Metabolism

Time-limited diets and the gut microbiota in cardiometabolic disease

Karina Ratiner, Hagit Shapiro, Kim Goldenberg, Eran Elinav

Summary: Intermittent fasting is considered a promising treatment for cardiometabolic diseases and has positive effects on the gut microbiome and the host circadian clock. This review discusses the relationship between gut microbiome alterations and intermittent fasting's impact on mammalian metabolism and cardiovascular diseases, highlighting the challenges of linking bacterial signals with dietary cues and incorporating microbiome into precision medicine.

JOURNAL OF DIABETES (2022)

Article Biochemical Research Methods

Dimensionality reduction of longitudinal 'omics data using modern tensor factorizations

Uria Mor, Yotam Cohen, Rafael Valdes-Mas, Denise Kviatcovsky, Eran Elinav, Haim Avron

Summary: Longitudinal 'omics analytical methods are widely used in precision medicine to analyze complex datasets and uncover individual variations in response to perturbations. However, technical limitations often generate feature-rich and sample-limited datasets that are challenging to analyze using conventional methods. This study presents TCAM, a new unsupervised tensor factorization method, which preserves the geometric and statistical traits of the data and allows for out-of-sample extension. re-analyses of real-world datasets confirm TCAM's utility in analyzing longitudinal 'omics data.

PLOS COMPUTATIONAL BIOLOGY (2022)

Review Medicine, Research & Experimental

Smoking-induced microbial dysbiosis in health and disease

Hagit Shapiro, Kim Goldenberg, Karina Ratiner, Eran Elinav

Summary: Smoking is associated with increased risks of cancer, pulmonary and cardiovascular diseases, and it can impact the composition and function of the microbiome in various parts of the body. Understanding the role of the microbiome can aid in developing rational therapies for smoking-related diseases and smoking cessation.

CLINICAL SCIENCE (2022)

Review Biochemistry & Molecular Biology

Local and systemic effects of microbiome-derived metabolites

Igor Spivak, Leviel Fluhr, Eran Elinav

Summary: Microbiomes form distinct ecosystems within their hosts and can impact the host's physiology through metabolite production, which may have therapeutic applications.

EMBO REPORTS (2022)

Review Physiology

Engineering bacteria to modulate host metabolism

Dragos Ciocan, Eran Elinav

Summary: The gut microbiota, composed of various microorganisms, has a significant impact on host metabolism and disease development. It can either have harmful effects or provide benefits to the host. Recently, therapeutic strategies targeting the gut microbiota, such as the use of engineered bacteria, have been developed to modulate the microbiota for the treatment of metabolic disorders.

ACTA PHYSIOLOGICA (2023)

Editorial Material Nutrition & Dietetics

Diversifying nutritional sciences-dietary practices and gut bacteria in individuals of Latino and Hispanic ancestry

Avner Leshem, Eran Elinav

AMERICAN JOURNAL OF CLINICAL NUTRITION (2023)

Review Microbiology

Impact of caloric restriction on the gut microbiota

Lara Kern, Denise Kviatcovsky, Yiming He, Eran Elinav

Summary: The impact of restrictive diets on gut microbiota composition and function, as well as their overall influences on host health and disease risk, are discussed. The evidence of long-term efficacy, adverse effects, and mechanisms of activity of caloric restriction and related diets is currently incomplete.

CURRENT OPINION IN MICROBIOLOGY (2023)

Review Gastroenterology & Hepatology

Fungi and cancer

Aurelia Saftien, Jens Puschhof, Eran Elinav

Summary: This review highlights the potential role of commensal and pathogenic fungi in modulating cancer-related processes and explores the mechanisms by which fungi influence tumor biology. It discusses the prospects of using fungi-related molecular signatures in cancer diagnosis, patient stratification, and assessment of treatment responsiveness. The review also emphasizes the challenges and limitations in conducting such research. Overall, it demonstrates that fungi likely play significant roles in mucosal and tumor-residing microbiomes and suggests the potential utilization of fungal inter-kingdom interactions in cancer diagnosis and treatment.
Editorial Material Biochemistry & Molecular Biology

Human microbiome research: Growing pains and future promises

Jens Puschhof, Eran Elinav

Summary: Human microbiome research is transitioning from association-based studies to understanding the effects of active strains on the human body. Despite challenges, progress has been made in utilizing data-driven microbiome diagnostics and interventions, potentially leading to breakthroughs in precision medicine in the next decade.

PLOS BIOLOGY (2023)

Article Biotechnology & Applied Microbiology

Ex vivo intestinal permeability assay (X-IPA) for tracking barrier function dynamics

Hadar Bootz-Maoz, Ariel Simon, Sara Del Mare-Roumani, Yifat Bennet, Einat Toister, Hadar Romano, Danping Zheng, Sivan Amidror, Eran Elinav, Nissan Yissachar

Summary: In this study, the researchers developed an ex vivo intestinal permeability assay, X-IPA, for quantitative analysis of gut permeability dynamics. They found that specific gut microbes and metabolites can rapidly and dose-dependently increase gut permeability, providing a powerful tool for investigating barrier functions.

NPJ BIOFILMS AND MICROBIOMES (2023)

Review Biotechnology & Applied Microbiology

Intracellular bacteria in cancer-prospects and debates

Lena Schorr, Marius Mathies, Eran Elinav, Jens Puschhof

Summary: Recent evidence suggests that some human cancers may contain low-biomass microbial ecosystems, including bacteria, viruses, and fungi. Bacteria, being the most studied group, are found to localize within cancer cells, immune cells, and other tumor microenvironment cell types, potentially impacting various cancer-related functions. By integrating sequencing-based and spatial techniques, the identification of bacterial tumor niches is made possible. However, proving the existence and function of intratumoral microbes in cancer remains a challenge.

NPJ BIOFILMS AND MICROBIOMES (2023)

Review Oncology

CAR-T Cell Therapy and the Gut Microbiota

Sahana Asokan, Nyssa Cullin, Christoph K. Stein-Thoeringer, Eran Elinav

CANCERS (2023)

暂无数据